Osteoporosis overview: Difference between revisions

Jump to navigation Jump to search
(→‎Overview: From CZ)
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Osteoporosis}}
{{Osteoporosis}}
{{CMG}}; '''Associate Editor(s)-In-Chief:''' {{CZ}}, [[User:Raviteja Reddy Guddeti|Raviteja Guddeti, M.B.B.S.]][mailto:ravitheja.g@gmail.com]  
{{CMG}}; {{AE}} {{CZ}}, [[User:Raviteja Reddy Guddeti|Raviteja Guddeti, M.B.B.S.]][mailto:ravitheja.g@gmail.com]  


==Overview==
==Overview==
Line 7: Line 7:


[[Clinical practice guideline]]s are available from both non-specialty organizations<ref name="pmid18794560">{{cite journal| author=Qaseem A, Snow V, Shekelle P, Hopkins R, Forciea MA, Owens DK et al.| title=Pharmacologic treatment of low bone density or osteoporosis to prevent fractures: a clinical practice guideline from the American College of Physicians. | journal=Ann Intern Med | year= 2008 | volume= 149 | issue= 6 | pages= 404-15 | pmid=18794560 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18794560  }} </ref><ref name="pmid21242341">{{cite journal| author=U.S. Preventive Services Task Force| title=Screening for osteoporosis: U.S. preventive services task force recommendation statement. | journal=Ann Intern Med | year= 2011 | volume= 154 | issue= 5 | pages= 356-64 | pmid=21242341 | doi=10.1059/0003-4819-154-5-201103010-00307 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21242341  }} </ref> and specialty societies<ref name="pmid20061894">{{cite journal| author=| title=Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society. | journal=Menopause | year= 2010 Jan-Feb | volume= 17 | issue= 1 | pages= 25-54; quiz 55-6 | pmid=20061894 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=clinical.uthscsa.edu/cite&email=badgett@uthscdsa.edu&retmode=ref&cmd=prlinks&id=20061894 | doi=10.1097/gme.0b013e3181c617e6 }} <!--Formatted by http://sumsearch.uthscsa.edu/cite/--></ref><ref name="NOF-2008">National Osteoporosis Foundation. [http://www.nof.org/professionals/Clinicians_Guide.htm Clinician's Guide to Prevention and Treatment of Osteoporosis]. Washington, DC: National Osteoporosis Foundation;2008.</ref>.
[[Clinical practice guideline]]s are available from both non-specialty organizations<ref name="pmid18794560">{{cite journal| author=Qaseem A, Snow V, Shekelle P, Hopkins R, Forciea MA, Owens DK et al.| title=Pharmacologic treatment of low bone density or osteoporosis to prevent fractures: a clinical practice guideline from the American College of Physicians. | journal=Ann Intern Med | year= 2008 | volume= 149 | issue= 6 | pages= 404-15 | pmid=18794560 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18794560  }} </ref><ref name="pmid21242341">{{cite journal| author=U.S. Preventive Services Task Force| title=Screening for osteoporosis: U.S. preventive services task force recommendation statement. | journal=Ann Intern Med | year= 2011 | volume= 154 | issue= 5 | pages= 356-64 | pmid=21242341 | doi=10.1059/0003-4819-154-5-201103010-00307 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21242341  }} </ref> and specialty societies<ref name="pmid20061894">{{cite journal| author=| title=Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society. | journal=Menopause | year= 2010 Jan-Feb | volume= 17 | issue= 1 | pages= 25-54; quiz 55-6 | pmid=20061894 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=clinical.uthscsa.edu/cite&email=badgett@uthscdsa.edu&retmode=ref&cmd=prlinks&id=20061894 | doi=10.1097/gme.0b013e3181c617e6 }} <!--Formatted by http://sumsearch.uthscsa.edu/cite/--></ref><ref name="NOF-2008">National Osteoporosis Foundation. [http://www.nof.org/professionals/Clinicians_Guide.htm Clinician's Guide to Prevention and Treatment of Osteoporosis]. Washington, DC: National Osteoporosis Foundation;2008.</ref>.
==Historical Perspective==
==Classification==


==Pathophysiology==
==Pathophysiology==
Line 13: Line 17:
==Causes==
==Causes==
[[Osteoporosis]] is caused by imbalance between bone resorption and bone formation.  The most common causes of osteoporosis include[[aging]], [[chronic renal failure]], nutritional deficiency of [[calcium]] and / or [[vitamin D]], immobility, [[hyperparathyroidism]], [[menopause]], and chronic [[glucocorticoid]] abuse.
[[Osteoporosis]] is caused by imbalance between bone resorption and bone formation.  The most common causes of osteoporosis include[[aging]], [[chronic renal failure]], nutritional deficiency of [[calcium]] and / or [[vitamin D]], immobility, [[hyperparathyroidism]], [[menopause]], and chronic [[glucocorticoid]] abuse.
==Differentiating Osteoporosis from other Diseases==
[[Osteoporosis]] must be distinguished from [[Idiopathic transient osteoporosis of hip]], [[osteomalacia]], [[scurvy]], [[osteogenesis imperfecta]], [[multiple myeloma]], [[homocystinuria]] and [[hypermetabolic resorptive osteoporosis]] which can also present with similar features.


==Epidemiology and Demographics==
==Epidemiology and Demographics==
Line 19: Line 26:
==Risk Factors==
==Risk Factors==
Risk factors for [[osteoporosis]] include both non-modifiable risk factors, such as advanced age, female gender, and causcasian or asian race, and modifiable risk factors such as alcohol use, steroid use, smoking, poor diet and lack of exercise.
Risk factors for [[osteoporosis]] include both non-modifiable risk factors, such as advanced age, female gender, and causcasian or asian race, and modifiable risk factors such as alcohol use, steroid use, smoking, poor diet and lack of exercise.
==Differentiating Disease from other Conditions==
[[Osteoporosis]] must be distinguished from [[Idiopathic transient osteoporosis of hip]], [[osteomalacia]], [[scurvy]], [[osteogenesis imperfecta]], [[multiple myeloma]], [[homocystinuria]] and [[hypermetabolic resorptive osteoporosis]] which can also present with similar features.


==Natural History, Complications and Prognosis==
==Natural History, Complications and Prognosis==
Line 33: Line 37:
[[Osteoporosis]] is associated with the presence of fractures on physical examination.
[[Osteoporosis]] is associated with the presence of fractures on physical examination.


===Laboratory Studies===
===Laboratory Findings===
Laboratory tests for the diagnosis of [[osteoporosis]] include some baseline tests including a complete blood count (CBC), serum calcium, serum phosphate, alkaline phosphatase, and  25(OH) vitamin D, as well as tests for diagnosing secondary osteoporosis, which include 24 hr serum calcium, serum protein electrophoresis, and bone marrow biopsy.
Laboratory tests for the diagnosis of [[osteoporosis]] include some baseline tests including a complete blood count (CBC), serum calcium, serum phosphate, alkaline phosphatase, and  25(OH) vitamin D, as well as tests for diagnosing secondary osteoporosis, which include 24 hr serum calcium, serum protein electrophoresis, and bone marrow biopsy.
===Electrocardiogram===
===Chest X Ray===
===CT===
===MRI===
===Echocardiography or Ultrasound===
===Other Imaging Findings===
===Other Diagnostic Studies===


==Treatment==
==Treatment==
Line 40: Line 58:
Drugs, especially [[bisphosphonates]] are the main medications in the treatment of osteoporosis.  However, lifestyle changes are also emphasized.  No treatment can completely reverse established [[osteoporosis]].  Medical management can only halt the progression of the disease process.
Drugs, especially [[bisphosphonates]] are the main medications in the treatment of osteoporosis.  However, lifestyle changes are also emphasized.  No treatment can completely reverse established [[osteoporosis]].  Medical management can only halt the progression of the disease process.


===Surgical therapy===
===Surgery===
Surgical therapy is employed for fractures caused by [[osteoporosis]].  [[Vertebroplasty]] and [[kyphoplasty]] are used to treat patients with vertebral compression fractures.  For fractures of the hip open reduction and internal fixation is done.
Surgical therapy is employed for fractures caused by [[osteoporosis]].  [[Vertebroplasty]] and [[kyphoplasty]] are used to treat patients with vertebral compression fractures.  For fractures of the hip open reduction and internal fixation is done.
===Primary Prevention===
===Secondary Prevention===
===Cost-Effectiveness of Therapy===
===Future or Investigational Therapies===


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
{{WS}}
{{WH}}


{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
[[Category:Disease]]
[[Category:Geriatrics]]
[[Category:Aging-associated diseases]]
[[Category:Endocrinology]]
[[Category:Endocrinology]]
[[Category:Radiology]]
[[Category:Radiology]]
[[Category:Skeletal disorders]]
[[Category:Orthopedics]]
[[Category:Orthopedics]]
[[Category:Primary care]]
[[Category:Needs content]]

Revision as of 14:14, 13 July 2016

Osteoporosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Osteoporosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Life Style Modification
Pharmacotherapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Osteoporosis overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Osteoporosis overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Osteoporosis overview

CDC on Osteoporosis overview

Osteoporosis overview in the news

Blogs on Osteoporosis overview

Directions to Hospitals Treating Osteoporosis

Risk calculators and risk factors for Osteoporosis overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2], Raviteja Guddeti, M.B.B.S.[3]

Overview

Osteoporosis is a disease of the bone characterized by low bone mineral density. which leads to an increased risk of fracture. The pathology involves negative balance between bone resorption and new bone formation. Aging, female gender, thin and small stature, asian or caucasian race, alcoholism, hypogonadism, and steroid abuse are among the primary risk factors associated with osteoporosis. It can be prevented with lifestyle modification, calcium and vitamin D supplementation, and medication. Preventing falls in people with known or suspected osteoporosis is an established way to prevent fractures. Bisphosphonates, calcium, and vitamin D supplementation form the main stay of treatment.

Clinical practice guidelines are available from both non-specialty organizations[1][2] and specialty societies[3][4].

Historical Perspective

Classification

Pathophysiology

The pathophysiology of osteoporosis involves an imbalance between bone resorption and bone formation, leading to poor mineralization and fragility of the bone. Factors that contribute to the development of osteoporosis include advanced age, female sex and hypogonadism.

Causes

Osteoporosis is caused by imbalance between bone resorption and bone formation. The most common causes of osteoporosis includeaging, chronic renal failure, nutritional deficiency of calcium and / or vitamin D, immobility, hyperparathyroidism, menopause, and chronic glucocorticoid abuse.

Differentiating Osteoporosis from other Diseases

Osteoporosis must be distinguished from Idiopathic transient osteoporosis of hip, osteomalacia, scurvy, osteogenesis imperfecta, multiple myeloma, homocystinuria and hypermetabolic resorptive osteoporosis which can also present with similar features.

Epidemiology and Demographics

Osteoporosis is a major health problem affecting 44 million people in the United States. The disease is most common in females over the age of 50.

Risk Factors

Risk factors for osteoporosis include both non-modifiable risk factors, such as advanced age, female gender, and causcasian or asian race, and modifiable risk factors such as alcohol use, steroid use, smoking, poor diet and lack of exercise.

Natural History, Complications and Prognosis

Osteoporosis can be complicated by the development of fractures. The prognosis is good. Mortality from the disease depends on the type of fracture. The major type of fractures contributing to mortality in these patients are vertebral fractures and hip fractures.

Diagnosis

Symptoms

Osteoporosis itself has no symptoms, until a fracture due to brittle bones has already occurred. The disease state causes increased fragility of the bones and thus making them more prone to fractures. The precursor disease to osteoporosis is osteopenia, which is poor mineralization of the bone, which can only be diagnosed through medical tests.

Physical Examination

Osteoporosis is associated with the presence of fractures on physical examination.

Laboratory Findings

Laboratory tests for the diagnosis of osteoporosis include some baseline tests including a complete blood count (CBC), serum calcium, serum phosphate, alkaline phosphatase, and 25(OH) vitamin D, as well as tests for diagnosing secondary osteoporosis, which include 24 hr serum calcium, serum protein electrophoresis, and bone marrow biopsy.

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical therapy

Drugs, especially bisphosphonates are the main medications in the treatment of osteoporosis. However, lifestyle changes are also emphasized. No treatment can completely reverse established osteoporosis. Medical management can only halt the progression of the disease process.

Surgery

Surgical therapy is employed for fractures caused by osteoporosis. Vertebroplasty and kyphoplasty are used to treat patients with vertebral compression fractures. For fractures of the hip open reduction and internal fixation is done.

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

References

  1. Qaseem A, Snow V, Shekelle P, Hopkins R, Forciea MA, Owens DK; et al. (2008). "Pharmacologic treatment of low bone density or osteoporosis to prevent fractures: a clinical practice guideline from the American College of Physicians". Ann Intern Med. 149 (6): 404–15. PMID 18794560.
  2. U.S. Preventive Services Task Force (2011). "Screening for osteoporosis: U.S. preventive services task force recommendation statement". Ann Intern Med. 154 (5): 356–64. doi:10.1059/0003-4819-154-5-201103010-00307. PMID 21242341.
  3. "Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society". Menopause. 17 (1): 25–54, quiz 55-6. 2010 Jan-Feb. doi:10.1097/gme.0b013e3181c617e6. PMID 20061894. Check date values in: |year= (help)
  4. National Osteoporosis Foundation. Clinician's Guide to Prevention and Treatment of Osteoporosis. Washington, DC: National Osteoporosis Foundation;2008.

Template:WS Template:WH